...
首页> 外文期刊>Cancer biology & therapy >Systemic Par-4 inhibits non-autochthonous tumor growth.
【24h】

Systemic Par-4 inhibits non-autochthonous tumor growth.

机译:全身性Par-4抑制非自发性肿瘤生长。

获取原文
获取原文并翻译 | 示例
           

摘要

The tumor suppressor protein Par-4 (Prostate apoptosis response-4) is spontaneously secreted by normal and cancer cells. Extracellular Par-4 induces caspase-dependent apoptosis in cancer cell cultures by binding, via its effector SAC domain, to cell surface GRP78 receptor. However, the functional significance of extracellular Par-4/SAC has not been validated in animal models. We show that Par-4/SAC-transgenic mice express systemic Par-4/SAC protein and are resistant to the growth of non-autochthonous tumors. Consistently, secretory Par-4/SAC pro-apoptotic activity can be transferred from these cancer-resistant transgenic mice to cancer-susceptible mice by bone marrow transplantation. Moreover, intravenous injection of recombinant Par-4 or SAC protein inhibits metastasis of cancer cells. Collectively, our findings indicate that extracellular Par-4/SAC is systemically functional in inhibition of tumor growth and metastasis progression, and may merit investigation as a therapy.
机译:正常细胞和癌细胞自发分泌肿瘤抑制蛋白Par-4(前列腺细胞凋亡反应4)。细胞外Par-4通过其效应子SAC结构域与细胞表面GRP78受体结合,从而在癌细胞培养物中诱导caspase依赖性凋亡。但是,细胞外Par-4 / SAC的功能意义尚未在动物模型中得到验证。我们显示,Par-4 / SAC转基因小鼠表达全身性的Par-4 / SAC蛋白,并且对非自发性肿瘤的生长具有抗性。一致地,分泌的Par-4 / SAC促凋亡活性可以通过骨髓移植从这些抗癌的转基因小鼠转移到易癌的小鼠。而且,静脉内注射重组Par-4或SAC蛋白可抑制癌细胞的转移。总的来说,我们的发现表明细胞外Par-4 / SAC在抑制肿瘤生长和转移进程中具有系统性功能,可能值得进行治疗研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号